OverviewChartNewsTraderScreen

JP Morgan Put 440 LLY 16.01.2026/  DE000JK7RP42  /

EUWAX
5/31/2024  11:37:04 AM Chg.0.000 Bid10:00:39 PM Ask10:00:39 PM Underlying Strike price Expiration date Option type
0.130EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 ELI LILLY 440.00 - 1/16/2026 Put
GlobeNewswire 5/30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 5/30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 5/24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 5/24 Eli Lilly to reveal $5.3B production boost
GlobeNewswire 5/23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 5/23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 5/23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
TeleTrader 5/21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 5/16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 5/16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 5/16 HEPHAISTOS secures €10.3 M to reach the clinical stage
GlobeNewswire 5/15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 5/13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 5/9 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire 5/9 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 5/8 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 5/8 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 5/8 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 5/8 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire 5/8 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
GlobeNewswire 5/3 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire 5/1 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire 4/30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
TeleTrader 4/30 Eli Lilly's Q1 revenue surges 26% to $8.8B